References
- 1. European Cardiovascular Disease Statistics 2017. Avaible at: http://www.ehnheart.org/cvd-statistics.html
- 2. Konstam MA, Kramer DG, Patel AR, et al. Left ventricular remodeling in heart failure current concepts in clinical significance and assessment. J Am Coll Cardiol Img. 2011;4:98-108.
- 3. Abbate A, Biondi-Zoccai GG, Appleton DL, et al. Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a meta-analysis of randomized controlled clinical trials. J Am Coll Cardiol. 2008;21:956-964.
- 4. David G, David AB. MRI determination of myocardial viability. Appl Radiol. 2006;35.
- 5. Frangioni JV, Hajjar RJ. In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation. 2004;110:3378-3383.
- 6. Chen IY, Wu JC. Cardiovascular molecular imaging: focus on clinical translation. Circulation. 2011;123:425-443.
- 7. Comella K, Griffeth J. Stem Cell Research in the Cardiac Field: Where Are We Now? World Stem Cell Report. 2009.
- 8. Krishna KA, Krishna KS, Berrocal R, Rao KS, Sambasiva Rao KRS. Myocardial infarction and stem cells. Myocardial infarction and stem cells. J Pharm Bioallied Sci. 2011;3:182-188.
- 9. Perin EC, López J. Methods of stem cell delivery in cardiac diseases. Nat Clin Pract Cardiovasc Med. 2006:Suppl1:110-113.
- 10. Bodo-Eckehard S, Gustav S. 10 Years of Intracoronary and Intramyocardial Bone Marrow Stem Cell Therapy of the Heart. J Am Coll Cardiol. 2011;58:1095-1104.
- 11. Whitney F, Rony A. Therapeutic use of stem cells for cardiovascular disease. Clin Transl Med. 2016;5:34.
- 12. Donndorf P, Strauer BE. Stem cell therapy for the treatment of acute myocardial infarction and chronic ischemic heart disease. Curr Pharm Biotechnol. 2013;14:12-19.
- 13. Lau JF, Anderson SA, Adler E, Frank JA. Imaging approaches for the study of cell-based cardiac therapies. Nat Rev Cardiol. 2009;7:97-105.
- 14. Mahrholdt H, Wagner A, Holly TA, et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation. 2002;106: 2322-2327.
- 15. Al Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation. 2000;101:1379-1383.
- 16. Baer FM, Theissen P, Schneider CA, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol. 1998;31:1040-1048.
- 17. Hassan AA, Anja Z. Delayed Enhancement and T2-Weighted Cardiovascular Magnetic Resonance Imaging Differentiate Acute From Chronic Myocardial Infarction. Circulation. 2003;107:2290-2293.
- 18. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374-379.
- 19. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J. 2007;28:2525-2538.
- 20. Dash R, Kim PJ, Matsuura Y, et al. Manganese-enhanced MRI enables in vivo confirmation of peri-infarct restoration following stem cell therapy in porcine ischemia-reperfusion model. J Am Heart Assoc. 2015;4:e002044.
- 21. Choi KM, Kim RJ, Gubernikoff G, et al. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation. 2001;104:1101-1107.
- 22. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JAC. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation. 2002;106:1083-1089.
- 23. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation.1999;100:1992-2002.
- 24. van Assche LMR, Kim HW, Kim RJ. Cardiac Mr For The Assessment Of Myocardial Viability. Methodist Debakey Cardiovascular Journal. 2013;9:163-168.
- 25. Romero J, Xue X, Gonzalez W, et al. CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials. JACC Cardiovasc Imaging. 2012;5:494-508.
- 26. Cwajg JM, Cwajg E, Nagueh SF, et al. End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution T1-201 tomography and dobutamine stress echocardiography. J Am Coll Cardiol. 2000;35:1152-1161.
- 27. Shah DJ, Kim HW, Elliott M, et al. Contrast MRI predicts reverse remodeling and contractile improvement in akinetic thinned myocardium. Circulation. 2003;108:697.
- 28. Wu YW, Tadamura E, Yamamuro M, et al. Comparison of contrast-enhanced MRI with (18) F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease. J Nucl Med. 2007;48:1096-1103.
- 29. Grover S, Srinivasan G, Selvanayagam JB. Myocardial viability imaging: does it still have a role in patient selection prior to coronary revascularisation? Heart Lung Circ. 2012;21:468-479.
- 30. Xi L, Rui X, Zhang B, Gao F. MRI tracking stem cells transplantation for coronary heart disease. Pak J Med Sci. 2014;30:899-903.
- 31. Sterenczak KA, Meier M, Glage S, et al. Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer. BMC Cancer. 2012;12:284.
- 32. Guenoun J, Koning GA, Doeswijk G, et al. Cationic Gd-DTPA liposomes for highly efficient labeling of mesenchymal stem cells and cell tracking with MRI. Cell Transplant. 2012;21:191-205.
- 33. Mamani JB, Pavon LF, Miyaki LA, et al. Intracellular labeling and quantification process by magnetic resonance imaging using iron oxide magnetic nanoparticles in rat C6 glioma cell line. Einstein. 2012;10:216-221.
- 34. Vuong QL, Van Doorslaer S, Bridot JL, et al. Paramagnetic nanoparticles as potential MRI contrast agents: characterization, NMR relaxation, simulations and theory. MAGMA. 2012; 25:467-478.
- 35. Bowen CV, Zhang X, Saab G, Gareau PJ, Rutt BK. Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn Reson Med. 2002;48:52-61.
- 36. Moriel V. Cardiac Cell Tracking with MRI Reporter Genes: Welcoming a New Field. Curr Cardiovasc Imaging Rep. 2014;7:9250.
- 37. Vandsburger MH, Radoul M, et al. MRI reporter genes: applications for imaging of cell survival, proliferation, migration and differentiation. NMR Biomed. 2013;26:872-84.
- 38. Lee SW, Lee SH, et al. Magnetic resonance reporter gene imaging. Theranostics.2012;2:403-12.
- 39. Naumova AV, Reinecke H, et al. Ferritin overexpression for noninvasive magnetic resonance imaging-based tracking of stem cells transplanted into the heart. Mol Imaging. 2010 Aug;9:201-210.
- 40. Naumova AV, Yarnykh VL, Cohen B, Neeman M. Quantification of MRI signal of transgenic grafts overexpressing ferritin in murine myocardial infarcts. NMR Biomedicine. 2012;25:1187-1195.
- 41. Moriel Vandsburger. Cardiac Cell Tracking with MRI Reporter Genes: Welcoming a New Field. Curr Cardiovasc Imaging Rep. 2014;7:9250.
- 42. Patricia KN, Feng L, Wang Y, Wu JC. Imaging: Guiding the Clinical Translation of Cardiac Stem Cell Therapy. Circ Res. 2011;109:962-979.
- 43. David E. Sosnovik. Seeing What We Build—The Need for New Imaging Techniques in Myocardial Regeneration. J Am Heart Assoc. 2015;4:e002306.
- 44. Cao F, Lin S, Xie X, et al. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation. 2006;113:1005-1014.
- 45. Terrovitis JV, Smith RR, Marbán E. Assessment and Optimization of Cell Engraftment after Transplantation into the Heart. Circ Res. 2010;106:479-494.
- 46. Amsalem Y, Mardor Y, Feinberg MS, et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation. 2007;116:38-45.
- 47. Terrovitis J, Stuber M, et al. Iron-labeled stem cells seen by magnetic resonance imaging: dead or alive? Circulation. 2006;114:264.
- 48. Partlow KC, Chen J, Brant J, Wickline SA. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J. 2007;21:1647-1654.
- 49. Berry MF, Engler AJ, Woo YJ, et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol. 2006;290:2196-2203.
- 50. Nesteruk J, Voronina N, Kundt G, et al. Stem cell registry programme for patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting: what benefits does it derive? ESC Heart Fail. 2017;4:105-111.
- 51. Traverse JH, Henry TD, Pepine CJ, Willerson JT, Ellis SG. One-Year Follow-up of Intracoronary Stem Cell Delivery on Left-Ventricular Function Following ST-Elevation Myocardial Infarction. JAMA. 2014;311:301-302.
- 52. Malliaras K, Makkar RR, Smith RR, et al. Intracoronary Cardiosphere-Derived Cells After Myocardial Infarction: Evidence of Therapeutic Regeneration in the Final 1-Year Results of the CADUCEUS Trial. J Am Coll Cardiol. 2014;63(2):110-122.
- 53. Lipinski MJ, Biondi-Zoccai GG, Abbate A, Vetrovec GW. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol. 2007;50:1761-1767.
- 54. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J. 2008;29:1807-1818.
- 55. Delewi R, Hirsch A, Tijssen JG, et al. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis. Eur Heart J. 2014;35:989-998.
- 56. Jeevanantham V, Butler M, Saad A, et al. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation. 2012;126:551-568.